Human cord blood cells and myocardial infarction: Effect of dose and route of administration on infarct size

Cell Transplantation

Volumn 16, Issue 9, 2007, Pages 907-917

  Henning, Robert J ^a,c   Burgos, Jose D ^a   Vasko, Mark ^a   Alvarado, Felipe ^a   Sanberg, Cyndy D ^b   Sanberg, Paul R ^a   Morgan, Michael B ^d  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b Saneron CCEL Therapeutics Inc   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d NONE

Author keywords

Cell therapy; Coronary artery disease; Myocardial infarction; Stem cells

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ASCENDING AORTA; BLOOD CELL; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART MUSCLE; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MALE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; STEM CELL TRANSPLANTATION; UMBILICAL CORD BLOOD; ANIMAL; ARTICLE; COMPARATIVE STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOLOGY; FETUS BLOOD; HEMATOPOIETIC STEM CELL; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TIME; XENOGRAFT;

RATTUS;

ANIMALS; CORD BLOOD STEM CELL TRANSPLANTATION; FETAL BLOOD; HEMATOPOIETIC STEM CELLS; HUMANS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; MALE; MYOCARDIAL INFARCTION; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 41249093917     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368907783338299     Document Type: Conference Paper

References (40)

1. Abbott, J. D.; Huang, Y.; Liu, D.; Hickey, R.; Krause, D. S.; Giordano, F. J. Stromal cell-derived factor-1α plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 110:3300-3305; 2004.
2. Adegboyega, P. A.; Adesokan, A.; Haque, A. K.; Boor, P. J. Sensitivity and specificity of triphenyl tetrazolium chloride in the gross diagnosis of acute myocardial infarcts. Arch. Pathol. Lab. Med. 121:1063-1068; 1997.
3. American Heart Association heart and stroke statistics - 2006 update. www.americanheart.org.
4. Askari, A. T.; Unzek, S.; Popovic, Z. B.; Goldman, C. K.; Forudi, F.; Kiedrowski, M.; Rovner, A.; Ellis, S. G.; Thomas, J. D.; DiCorleto, P. E.; Topol, E. J.; Penn, M. S. Effect of stromal-cell-derived factor 1 on stem cell homing and tissue regeneration in ischemic cardiomyopathy. Lancet 362:697-703; 2003.
5. Broxmeyer, H. E. Cord blood: Biology, immunology, banking and clinical transplantation. Bethesda, MD: AABB Press; 2004.
6. Chen, S. L.; Fang, W. W.; Ye, F.; Liu, Y. H.; Qian, J.; Shan, S. J.; Zhang, J. J.; Chunhua, R. Z.; Liao, L. M.; Lin, S.; Sun, J. P. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction. Am. J. Cardiol. 94:92-95; 2004.
7. Cheng, W.; Reiss, K.; Li, P.; Chun, M. J.; Kajstura, J.; Olivetti, G.; Anversa, P. Aging does not affect the activation of the myocyte insulin-like growth factor-1 autocrine system after infarction and ventricular failure in Fischer 344 rats. Circ. Res. 78:536-546; 1996.
8. Condorelli, G.; Borello, U.; DeAngelis, L.; Latronico, M.; Sirabella, D.; Coletta, M.; Galli, R.; Balconi, G.; Follenzi, A.; Frati, G.; Cusella De Angelis, M. G.; Gioglio, L.; Amuchastegui, S.; Adorini, L.; Naldini, L.; Vescovi, A.; Dejana, E.; Cossu, G. Cardiomyocytes induce endothelial cells to transdifferentiate into cardiac muscle: Implications for myocardium regeneration. Proc. Natl. Acad. Sci. USA 98:10733-10738; 2001.
9. Dai, W.; Hale, S. L.; Martin, B. J.; Kuang, J. Q.; Dow, J. S.; Wold, L. E.; Kloner, R. A. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: Short-and long-term effects. Circulation 112:214-223; 2005.
10. Dib, N.; Michler, R. E.; Pagani, F. D.; Wright, S.; Kereiakes, D. J.; Lengerich, R.; Binkley, P.; Buchele, D.; Anand, I.; Swingen, C.; Di Carli, M. F.; Thomas, J. D.; Jaber, W. A.; Opie, S. R.; Campbell, A.; McCarthy, P.; Yeager, M.; Dilsizian, V.; Griffith, B. P.; Korn, R.; Kreuger, S. K.; Ghazoul, M.; MacLellan, W. R.; Fonarow, G.; Eisen, H. J.; Dinsmore, J.; Diethrich, E. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: Four-year follow-up. Circulation 112:1748-1755; 2005.
11. Erices, A.; Conget, P.; Minguell, J. J. Mesenchymal progenitor cells in human umbilical cord blood. Br. J. Haematol. 109:235-242; 2000.
12. Gnecchi, M.; He, H.; Liang, O. D.; Melo, L. G.; Morello, F.; Mu, H.; Noiseux, N.; Zhang, L.; Pratt, R. E.; Ingwall, J. S.; Dzau, V. J. Paracrine action accounts for the marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat. Med. 11:367-368; 2005.
13. Harris, D. T.; Schumacher, M. J.; Locascio, J.; Besencon, F. J.; Olson, G. B.; DeLuca, D.; Shenker, L.; Bard, J.; Boyse, E. A. Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. Proc. Natl. Acad. Sci USA 89:1006-1010; 1992.
14. Henning, R. J.; Abu-Ali, H.; Balis, J. B.; Morgan, M. B.; Willing, A. E.; Sanberg, P. R. Human umbilical cord progenitor cells in the treatment of acute myocardial infarction. J. Am. Coll. Cardiol. 43(5):1078-1092; 2004.
15. Henning, R. J.; Abu-Ali, H.; Balis, J. U.;, Morgan, M. B.; Willing, A. E.; Sanberg, P. R. Human umbilical cord blood mononuclear cells for the treatment of acute myocardial infarction. Cell Transplant. 13:729-739; 2004.
16. Henning, R. J.; Burgos, J. D.; Ondrovic, L.; Sanberg, P. R.; Balis, J. U.; Morgan, M. B. Human umbilical cord blood progenitor cells are attracted to infarcted myocardium and significantly reduce myocardial infarction size. Cell Transplant. 15:647-658; 2006.
17. Hirata, Y.; Sata, M.; Motomura, N.; Takanashi, M.; Suematsu, Y.; Ono, M.; Takamoto, S. Human umbilical cord blood cells improve cardiac function after myocardial infarction. Biochem. Biophys. Res. Commun. 327:609-614; 2005.
18. Kehat, I.; Kenyagin-Karsenti, D.; Snir, M.; Segev, H.; Amit, M.; Gepstein, A.; Livne, E.; Binah, O.; Itskovitz-Eldor, J.; Gepstein, L. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Invest. 108:407-414; 2001.
19. Kocher, A. A.; Schuster, M. D.; Szabolcs, M. J.; Takuma, S.; Burkhoff, D.; Wang, J.; Homma, S.; Edwards, N. M.; Itescu, S. Neovascularization of ischemic myocardium by human bone marrow derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7:430-436; 2001.
20. Laflamme, M. A.; Gold, J.; Xu, C.; Hassanipour, M.; Rosler, E.; Police, S.; Muskheli, V.; Murry, C. E. Formation of human myocardium in the rat heart from human embryonic stem cells. Am. J. Pathol. 3:663-671; 2005.
21. Ma, J.; Ge, J.; Zhang, S.; Sun, A.; Shen, J.; Chen, L.; Wang, K.; Zou, Y. Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction. Basic Res. Cardiol. 100:217-223; 2005.
22. Makino, S.; Fukuda, K.; Miyoshi, S.; Konishi, F.; Kodama, H.; Pan, J.; Sano, M.; Takahashi, T.; Hori, S.; Abe, H.; Hata, J.; Umezawa, A.; Ogawa, S. Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest. 103:697-705; 1999.
23. Menasche, P.; Hagege, A. A.; Vilquin, J. T.; Desnos, M.; Abergel, E.; Pouzet, B.; Bel, A.; Sarateanu, S.; Scorsin, M.; Schwartz, K.; Bruneval, P.; Benbunan, M.; Marolleau, J. P.; Duboc, D. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J. Am. Coll. Cardiol. 41:1077-1083; 2003.
24. Murohara, T.; Ikeda, H.; Duan, J.; Shintani, S.; Sasaki, K.; Eguchi, H.; Onitsuka, I.; Matsui, K.; Imaizumi, T. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J. Clin. Invest. 105:1527-1536; 2000.
25. Murry, C. E.; Field, L. J.; Menasché, P. Cell-based cardiac repair: reflections at the 10-year point. Circulation 112:3174-3183; 2005.
26. Murry, C. E.; Reinecke, H.; Pabon, L. M. Regeneration gaps. Observations on stem cells and cardiac repair. J. Am. Coll. Cardiol. 47:1777-1785; 2006.
27. Nieda, M.; Nicol, A.; Denning-Kendall, P.; Sweetenham, J.; Bradley, B.; Hows, J. Endothelial cell precursors are normal components of human umbilical cord blood. Br. J. Haematol. 98:775-777; 1997.
28. Pesce, M.; Orlandi, A.; Iachininoto, M. G.; Straino, S.; Torella, A. R.; Rizzuti, V.; Pompilio, G.; Bonanno, G.; Scambia, G.; Capogrossi, M. C. Myoendothelial differentiation of human umbilical cord blood-derived stem cells in ischemic limb tissues. Circ. Res. 93:e51-e62; 2003.
29. Risdon, G.; Gaddy, J.; Stehman, F. B.; Broxmeyer, H. E. Proliferative and cytotoxic response of human cord blood T lymphocytes following allogeneic stimulation. Cell. Immunol. 154:14-24; 1994.
30. Rota, M.; LeCapitaine, N.; Hosoda, T.; Boni, A.; De Angelis, A.; Padin-Iruegas, M. E.; Espositio, G.; Vitale, S.; Urbanek, K.; Casarsa, C.; Giorgio, M.; Luscher, T. F.; Pelicci, P. G.; Anversa, P.; Leri, A.; Kajstura, J. Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene. Circ. Res. 99:42-52; 2006.
31. Strauer, B. E.; Brehm, M.; Zeus, T.; Kostering, M.; Hernandez, A.; Sorq, R. V.; Kogler, G.; Wernet, P. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106:1913-1918; 2002.
32. Taylor, S.; Bryson, Y. J. Impaired production of gamma-interferon by newborn cells in-vitro due to functionally immature macrophages. J. Immunol. 134:;1493-1497; 1985.
33. Tomita, S.; Li, R. K.; Weisel, R. D.; Mickle, D. A.; Kim, E. J.; Sakai, T.; Jia, Z. Q. Autologous transplantation of bone marrow cells improve damaged heart function. Circulation 110:II247-II256; 1999.
34. Torella, D.; Rota, M.; Nurzynska, D.; Musso, E.; Monsen, A.; Shiraishi, I.; Zias, E.; Walsh, K.; Rosenzweig, A.; Sussman, M. A.; Urbanek, K.; Nadal-Ginard, B.; Kajstura, J.; Anversa, P.; Leri, A. Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ. Res. 94:514-524; 2004.
35. Tran, N.; Li, Y.; Maskali, F.; Antunes, L.; Maureira, P.; Laurens, M.-H.; Marie, P.-Y.; Karcher, G.; Groubatch, F.; Stoltz, J.-F.; Villemot, J.-P. Short-term retention and distribution of intramyocardial delivered mesencymal cells within necrotic or intact myocardium. Cell Transplant. 15:351-358; 2006.
36. Ueda, H.; Nakamura, T.; Matsumoto, K.; Sawa, Y.; Matsuda, H.; Nakamura, T. A potential cardioprotective role of hepatocyte growth factor in myocardial infarction in rats. Cardiovasc. Res. 51:41-50; 2001.
37. Urbanek, K.; Rota, M.; Cascapera, S.; Bearzi, C.; Nascimbene, A.; De Angelis, A.; Hosoda, T.; Chimenti, S.; Baker, M.; Limana, F.; Nurzynska, D.; Torella, D.; Rotatori, F.; Rastaldo, R.; Musso, E.; Quaini, F.; Leri, A.; Kajstura, J.; Anversa, P. Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ. Res. 97:663-673; 2005.
38. Vaziri, H.; Dragowska, W.; Allsopp, R. C.; Thomas, T. E.; Harley, C. B.; Lansdorp, P. M. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc. Nat. Acad. Sci. USA 91:9857-9860; 1994.
39. Vulliet, P. R.; Greeley, M.; Halloran, S. M.; MacDonald, K. A.; Kittleson, M. D. Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet 363:783-784; 2004.
40. Wollert, K. C.; Meyer, G. P.; Lotz, J.; Ringes-Lichtenberg, S.; Lippolt, P.; Breidenbach, C.; Fichtner, S.; Korte, T.; Hornig, B.; Messinger, D.; Arseniev, L.; Hertenstein, B.; Ganser, A.; Drexler, H. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomized controlled clinical trial. Lancet 364:141-148; 2004.